Literature DB >> 9593490

The Clostridium perfringens enterotoxin from equine isolates; its characterization, sequence and role in foal diarrhoea.

T Netherwood1, M Binns, H Townsend, J L Wood, J A Mumford, N Chanter.   

Abstract

During a survey of foal diarrhoea between 1991 and 1994, Clostridium perfringens was significantly associated with disease with 56% of cases infected [1]. The contribution of enterotoxigenic C. perfringens to this association, was assessed by use of the reverse passive latex agglutination test for enterotoxin (RPLA; Oxoid Unipath) and vero cell toxicity neutralized by antitoxin on stored faecal samples and sporulated faecal isolates of C. perfringens. Polymerase chain reaction (PCR1) based on the DNA sequence for the whole enterotoxin gene [2] yielded a fragment from an equine isolate of the anticipated size which, cloned into plasmid M13 phage, had a sequence essentially identical to the published sequence. Consequently, all faecal isolates were also tested by PCR1 and for a part of the enterotoxin gene (PCR2). Significant association with diarrhoea (controls not in contact with cases) was found with positive RPLA tests on faeces (OR = 13, P = 0.002) and isolates (OR = 4.57, P = < 0.0001), vero cell toxicity of isolates (OR = 1.78, P = 0.026), and PCR1 (OR = nd, P = 0.029) but not PCR2 or vero cell toxicity of faeces. Significant association with diarrhoea was also found for isolates negative by RPLA (OR = 3.91; CI 2.05-7.57; P < 0.0001) or PCR1 (OR = 4.81; CI 2.84-8.20; P < 0.0001). Many of the isolates from RPLA positive faeces and verotoxic isolates were PCR negative and no evidence could be found for the presence of the enterotoxin gene in a random selection of RPLA positive/PCR negative isolates by gene probe on chromosomal DNA and PCR reaction product or vero cell toxicity neutralized by specific antiserum. Failure of the vero cell toxicity on faeces to be associated with diarrhoea or for cytotoxicity of cultures and RPLA on cultures to agree with the PCRs was believed to be related to the presence of other cytotoxins, the inherent cytotoxicity of equine faeces and to the poor specificity of the commercial antiserum used in the test. Enterotoxigenic C. perfringens could not account for the overall association of C. perfringens with foal diarrhoea because (a) cultures positive by PCR, RPLA or cytotoxicity were not significantly more common amongst isolates from cases than controls; and (b) the proportion of isolates from cases positive by PCR (PCR1 or PCR2) was too small at 9.7%.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593490      PMCID: PMC2809390          DOI: 10.1017/s0950268897008534

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  5 in total

1.  Prevalence of netF-positive Clostridium perfringens in foals in southwestern Ontario.

Authors:  Abigail Finley; Iman Mehdizadeh Gohari; Valeria R Parreira; Miranda Abrahams; Henry R Staempfli; John F Prescott
Journal:  Can J Vet Res       Date:  2016-07       Impact factor: 1.310

2.  Probiotics shown to change bacterial community structure in the avian gastrointestinal tract.

Authors:  T Netherwood; H J Gilbert; D S Parker; A G O'Donnell
Journal:  Appl Environ Microbiol       Date:  1999-11       Impact factor: 4.792

Review 3.  NetF-producing Clostridium perfringens and its associated diseases in dogs and foals.

Authors:  Iman Mehdizadeh Gohari; Stefan Unterer; Ashley E Whitehead; John F Prescott
Journal:  J Vet Diagn Invest       Date:  2020-02-21       Impact factor: 1.279

Review 4.  A review of foal diarrhoea from birth to weaning.

Authors:  M Mallicote; A M House; L C Sanchez
Journal:  Equine Vet Educ       Date:  2012-01-18       Impact factor: 1.063

5.  Occurrence and Toxicogenetic Profiling of Clostridium perfringens in Buffalo and Cattle: An Update from Pakistan.

Authors:  Muhammad Umar Zafar Khan; Muhammad Humza; Shunli Yang; Mughees Aizaz Alvi; Muhammad Zahid Iqbal; Hafiza Zain-Ul-Fatima; Shumaila Khalid; Tahir Munir; Jianping Cai
Journal:  Toxins (Basel)       Date:  2021-03-13       Impact factor: 4.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.